Literature DB >> 28063042

Murine Models of Allergic Asthma.

Eline Haspeslagh1,2, Nincy Debeuf1,3, Hamida Hammad1,3, Bart N Lambrecht4,5.   

Abstract

Allergic asthma is a heterogeneous inflammatory lung disease affecting millions of people worldwide and with a steadily increasing incidence. Mouse models have been of utmost importance in uncovering key inflammatory cell types, cytokines, and pathways in the development and maintenance of allergic asthma. Historically, the mainstay in experimental asthma research was sensitizing rodents to the model protein antigen ovalbumin (OVA) with the pro-Th2 adjuvant aluminum hydroxide, followed by repetitive OVA exposures to the airways to initiate a Th2-skewed adaptive immune response leading to eosinophilic airway inflammation and airway hyperreactivity (AHR). In the last 5 years, OVA is often replaced by naturally occurring allergens such as house dust mite (HDM) or cockroach extracts, but the principle of first sensitizing and then repetitively challenging mice with the same antigen is unchanged. Here, we describe an often used and relevant HDM-based protocol to establish acute allergic asthma, and the methods we have developed to rapidly analyze inflammatory cell infiltration in the bronchalveolar lavage fluid by flow cytometry. Moreover, we explain the methods to restimulate T cells from lung-draining mediastinal lymph nodes with HDM to allow the measurement of cytokine secretion profiles of allergen reactive T cells.

Entities:  

Keywords:  Acute allergic asthma; Bronchoalveolar lavage; Eosinophilia; Flow cytometry; House dust mite (HDM); Mediastinal lymph nodes; Murine model; Ovalbumin (OVA)

Mesh:

Substances:

Year:  2017        PMID: 28063042     DOI: 10.1007/978-1-4939-6786-5_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

Review 1.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

Review 2.  Different Phenotypes in Asthma: Clinical Findings and Experimental Animal Models.

Authors:  Luiz Otávio Lourenço; Alessandra Mussi Ribeiro; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Iolanda de Fátima Lopes Calvo Tibério; Wothan Tavares-de-Lima; Carla Máximo Prado
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-20       Impact factor: 8.667

3.  Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis.

Authors:  Innokenty A Savin; Andrey V Markov; Marina A Zenkova; Aleksandra V Sen'kova
Journal:  Biomedicines       Date:  2022-04-28

4.  Rational targeting Cdc42 restrains Th2 cell differentiation and prevents allergic airway inflammation.

Authors:  Jun-Qi Yang; Khalid W Kalim; Yuan Li; Xin Duan; Phuong Nguyen; Gurjit K Khurana Hershey; John Kroner; Brandy Ruff; Li Zhang; Nathan Salomonis; Mark Rochman; Ting Wen; Yi Zheng; Fukun Guo
Journal:  Clin Exp Allergy       Date:  2018-11-13       Impact factor: 5.018

5.  Schistosoma japonicum infection downregulates house dust mite-induced allergic airway inflammation in mice.

Authors:  Sugan Qiu; Xiaolin Fan; Yingying Yang; Panpan Dong; Wei Zhou; Yongliang Xu; Yonghua Zhou; Fukun Guo; Yi Zheng; Jun-Qi Yang
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

6.  In vivo reprogramming of pathogenic lung TNFR2+ cDC2s by IFNβ inhibits HDM-induced asthma.

Authors:  Samira Mansouri; Himanshu Gogoi; Mauricio Pipkin; Tiago N Machuca; Amir M Emtiazjoo; Ashish K Sharma; Lei Jin
Journal:  Sci Immunol       Date:  2021-07-09

7.  Tulobuterol patch alleviates allergic asthmic inflammation by blockade of Syk and NF-κB activation in mice.

Authors:  Lixia Fu; Jing Guan; Yujia Zhang; Pei Ma; Yuanyuan Zhuang; Jinye Bai; Yasi Ding; Qi Hou; Wan Gong; Mingbao Lin; Wensheng Zheng; Jianmin Zhang
Journal:  Oncotarget       Date:  2018-01-31

Review 8.  Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis.

Authors:  Barbara C Mindt; Jörg H Fritz; Claudia U Duerr
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

9.  Antagonistic Peptides That Specifically Bind to the First and Second Extracellular Loops of CCR5 and Anti-IL-23p19 Antibody Reduce Airway Inflammation by Suppressing the IL-23/Th17 Signaling Pathway.

Authors:  Yingli Zhang; Rongrong Liang; Aicen Xie; Wenqian Shi; Huarong Huang; Yingqiang Zhong
Journal:  Mediators Inflamm       Date:  2020-04-28       Impact factor: 4.711

10.  Expression of vitamin D receptor in bronchial asthma and its bioinformatics prediction.

Authors:  Lishen Shan; Xinyuan Kang; Fen Liu; Xuxu Cai; Xiaohua Han; Yunxiao Shang
Journal:  Mol Med Rep       Date:  2018-06-13       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.